NCT05104697View on ClinicalTrials.gov

TMS for Improving Response Inhibition in Adolescents With OCD

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

August 1, 2023

Study Completion Date

September 1, 2023

Conditions
Obsessive-Compulsive Disorder
Interventions
DEVICE

Transcranial Magnetic Stimulation

All teens will receive active TMS; they will be randomly assigned to receive active TMS at either visit 1 or visit 2 (order counterbalanced)

Trial Locations (1)

02915

Emma Pendleton Bradley Hospital, Riverside

Sponsors

Collaborators (1)

Butler Hospital
All Listed Sponsors
collaborator

Butler Hospital

OTHER

collaborator

University of Minnesota

OTHER

lead

Bradley Hospital

OTHER

NCT05104697 - TMS for Improving Response Inhibition in Adolescents With OCD | Biotech Hunter | Biotech Hunter